Back to Industry Solutions

Solutions · Industry Solutions

Pharmaceutical grade water: GMP and pharmacopeia alignment

PW, WFI, and pure steam considerations: pretreatment, RO, EDI, distillation, sanitization, and documentation for validation-friendly systems.

Engineering knowledge guide2026pharmaGMPUSPPurified WaterWFIRO

Use when

Validation and change control make water systems expensive to fix after the fact; excursions hit batch release and audit observations.

Process options

URS-driven generation (RO/EDI vs distillation), loop sanitization strategy, instruments calibrated to pharmacopeia expectations, and clear sampling plans.

Assessment output

Consistent compendial quality, defendable data packages, and reduced reactive CAPA on the water system.

Inputs and conditions for an assessment

Collect feed variability, capacity, target quality, operating hours, discharge or reuse boundaries and installed equipment data. Compare examples on matched conditions and meter boundaries; assess a project using actual water data, equipment documentation and any necessary tests.

View the process illustration
Pharmaceutical grade water: GMP and pharmacopeia alignment water treatment solution illustration

Water Quality Targets & Regulatory Compliance

  • Purified Water (PW): Often produced by membrane and deionization technologies. Apply the current compendial conductivity procedure (the USP <645> Stage 1 value at 25 °C is 1.3 µS/cm) and TOC procedure (USP <643>, 500 µg/L). USP <1231> is informational: the commonly cited 100 CFU/mL microbial action level is not a PW monograph limit. Establish site alert/action levels and fitness-for-use criteria from qualification and intended use.
  • Water for Injection (WFI): Historically produced by distillation, some pharmacopoeias now permit membrane-based processes (e.g., EU Ph. Eur. Monograph 0169 for WFI). WFI has tighter limits for bacterial endotoxins (e.g., < 0.25 EU/mL, as per USP <85>), in addition to meeting PW specifications for conductivity and TOC.

Pharmaceutical purified-water process route with RO, EDI, UV, storage and sanitary distribution

1. Pretreatment – Safeguarding Membrane Integrity

Raw water sources, whether municipal or borewell, vary significantly in quality. High levels of suspended solids, organic matter, and colloids can lead to rapid biofouling and scaling of downstream reverse osmosis (RO) membranes.

  • Multimedia Filtration (MMF): Removes larger suspended solids and turbidity.
  • Ultrafiltration (UF): UF is one pretreatment option for removing suspended solids, colloids and microorganisms. Select it from actual-water testing and the RO element's feed-water requirements. Raw-water SDI₁₅ above 5 does not make UF universally mandatory; verify the quality achieved at the RO inlet and compare suitable pretreatment alternatives.
  • Chemical Dosing: Antiscalants are typically dosed upstream of the RO to prevent scaling by sparingly soluble salts (e.g., calcium carbonate, silica) at high recovery rates. pH adjustment may also be employed for optimal RO performance and scale control, particularly for LSI management.
  • Activated Carbon Filtration: Removes chlorine, chloramines, and certain organic compounds that can damage RO membranes.

3. Continuous Electrodeionization (EDI) – Post-RO Polishing

EDI technology continuously removes residual ions from the RO permeate without the need for periodic chemical regeneration of ion exchange resins, crucial for pharmaceutical environments.

  • Continuous Regeneration: A direct current (DC) field moves ions through selective membranes into concentrate compartments. Water splitting within the resin/membrane stack supplies H+ and OH- for continuous resin regeneration. Electrode-rinse arrangements depend on the module. EDI avoids routine acid/caustic resin regeneration, but system cleaning may still require chemicals.
  • High Purity Output: EDI consistently produces high-purity water (e.g., > 10 MΩ·cm resistivity, corresponding to < 0.1 µS/cm conductivity), suitable for PW and pre-WFI applications.

Operations, Monitoring, and CIP Philosophy

Robust operational strategies and continuous monitoring are paramount for maintaining validated water quality.

Risks and Common Engineering Mistakes

Ignoring proper design principles in pharmaceutical water systems can lead to significant compliance risks and operational headaches.

2026 Forward-Looking Context

Plan changes through the site's validated change-control process. Confirm the applicable pharmacopoeial edition, intended water use and sampling plan before changing treatment or sanitization conditions.

These categories typically support the approach above—open any line to compare brands and models.

For a closer review, use the engineering inquiry form to share feed, capacity, target, and project stage. Submission does not constitute a completed design or performance commitment.